Affiliation:
1. Doctoral Degree Program, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
2. Department of Clinical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
3. Department of Pulmonology and Respiratory Medicine, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia.
Abstract
This study identified non-tuberculous mycobacteria (NTM) isolates from the clinical respiratory specimen of patients suspected of chronic tuberculosis at a tertiary referral hospital in Indonesia. In this study, 20 clinical non-tuberculous mycobacteria (NTM) isolates were obtained from respiratory samples examined in the tuberculosis section of the Clinical Microbiology laboratory at Dr Soetomo General Hospital. The isolates were identified using TB Ag MPT 64 (SD Bioline) and targeting 16S rRNA genes sequence for analysis at the species level. Data on clinical features were collected and chest radiographs were evaluated. The highest bacterium found in the isolates was Mycobacterium kansasii (12 strains, 60%.), followed by Mycobacterium gordonae (2 strains, 5%), Mycobacterium parascofulaceum (2 strains, 5%), Mycobacterium avium (1 strain, 2.5%), Mycobacterium simiae (1 strain, 2.5%). Mycobacterium abcessus (1 strain, 2.5%), and Mycobacterium paraterrae (1 strain, 2.5%). Males dominated patients with Mycobacterium kansasii. Clinical symptoms include cough, dyspneu, hemoptysis, chest pain, and sweats. Half of the patients had a history of previous tuberculosis and other comorbid diabetes mellitus. Non-tuberculous mycobacteria (NTM) species identified were dominated by Mycobacterium kansasii. The predominance of non-tuberculous mycobacteria (NTM) species from clinical respiratory can be a reference to determine prudent treatment for patients in high-burden TB countries.
Reference44 articles.
1. Costa ARF da, Iii JOF, Lopes ML, et al. Occurrence of Nontuberculous Mycobacterial Pulmonary Infection in an Endemic Area of Tuberculosis. PLoS Negl Trop Dis. 2013; 7:e2340.doi.org/10.1371/journal.pntd.0002340
2. Ray S. QSAR Modeling of Antimycobacterial Activities of N-Benzylsalicylamides and N-Benzylsalicylthioamides Derivatives against Mycobacterium kansasii CNCTC My (235/80) Using Topological Parameter. Res J Pharm Technol. 2011; 4:1904–1909.
3. Jabe AS, Manhi K, Alfayyadh I, Hamim SS. Prevalence of Tuberculosis from 2010-2015 in Nasiriyah City/Iraq. Res J Pharm Technol. 2019; 12:2275–2278.doi.org/10.5958/0974-360X.2019.00379.2
4. Griffith DE, Aksamit TR. Nontuberculous Mycobacterial Disease Therapy: Take It to the Limit One More Time. Dis Chest. 2016; 150:1177–1178.doi.org/10.1016/j.chest.2016.07.015
5. Ratnatunga CN, Lutzky VP, Kupz A, et al. The Rise of Non-Tuberculosis Mycobacterial Lung Disease. Front Immunol. 2020; 11